Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP4-CHRONOS pilot trial
2019-001365-32Phase 2Unknown
- Sponsor
- Joint Research Compliance Office
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of finasteride and bicalutamide in prostate cancer (PCa) and prostate adenocarcinoma (4 arms), sponsored by Joint Research Compliance Office. Primary endpoint: Pilot phase feasibility and disease control (overall). Status: unknown.
02
Drugs
finasteridebicalutamide
03
Conditions
prostate cancer (PCa)prostate adenocarcinoma
Beyond the preview
Go deeper on 2019-001365-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001365-32.